Home
Dashboard
Curated content
Startups & Scaleups
SMEs & Corporates
Investors
Funding rounds
Accelerators
Universities
Governments & Non-profits
More organizations
Matching tool
Companies
ValenzaBio
Team
Team
Save
ValenzaBio
Developing therapies for autoimmune and inflammatory diseases.
Learn more
Launch date
2019
Employees
11-50 people
Market cap
-
Enterprise valuation
CAD382—573m
(Dealroom.co estimates Apr 2021.)
Bethesda Ohio (HQ)
http://valenzabiotech.com
https://www.linkedin.com/company/valenzabio/
B2B
manufacturing
health
biotechnology
hard tech
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Authorizing premium user...